Risk factors for selection of the L74I reverse transcriptase mutation in HIV-1 infected patients

被引：0
|
作者：
Marcelin, A. G.
Wirden, M.
Roquebert, B.
Derache, A.
Simon, A.
Ghosn, J.
Dominguez, S.
Katlama, C.
Calvez, V.
机构：
[1] Hop La Pitie Salpetriere, Dept Virol, Paris, France
[2] Hop La Pitie Salpetriere, Dept Internal Med, Paris, France
[3] Univ Paris 06, Paris, France
来源：
ANTIVIRAL THERAPY | 2006年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [1] Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patients
    Wirden, M
    Roquebert, W
    Derache, A
    Simon, A
    Duvivier, C
    Ghosn, J
    Dominguez, S
    Boutonnet, W
    Ait-Arkoub, Z
    Katlama, C
    Calvez, V
    Marcelin, AG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (07) : 2553 - 2556
  • [2] Significance of the L74V mutation in HIV-1 reverse transcriptase
    Goette, Matthias
    Wainberg, Mark A.
    FUTURE VIROLOGY, 2006, 1 (04) : 493 - 500
  • [3] The in vivo selection of mutations L74I/V is linked to combined nucleoside reverse transcriptase and non-nucleoside reverse transcriptase inhibitor exposure
    Camacho, R.
    Theys, K.
    Abecasis, A.
    Deforche, K.
    Carvalho, A. P.
    Cabanas, J.
    Gomes, P.
    Vandamme, A-M
    ANTIVIRAL THERAPY, 2006, 11 (05) : S164 - S164
  • [4] Selection of L74V mutation in reverse transcriptase of HIV-1 subtype D by a tenofovir DF-lamivudine based regimen
    Tamalet, Catherine
    Tomei, Christelle
    Henry, Mireille
    Solas, Caroline
    Villacian, Jorge
    Colson, Philippe
    AIDS, 2007, 21 (18) : 2551 - 2552
  • [5] High prevalence of integrase mutation L74I in West African HIV-1 subtypes prior to integrase inhibitor treatment
    El Bouzidi, Kate
    Kemp, Steven A.
    Datir, Rawlings P.
    Murtala-Ibrahim, Fati
    Aliyu, Ahmad
    Kwaghe, Vivian
    Frampton, Dan
    Roy, Sunando
    Breuer, Judith
    Sabin, Caroline A.
    Ogbanufe, Obinna
    Charurat, Man E.
    Bonsall, David
    Golubchik, Tanya
    Fraser, Christophe
    Dakum, Patrick
    Ndembi, Nicaise
    Gupta, Ravindra K.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (06) : 1575 - 1579
  • [6] Occurrence of HIV-1 reverse transcriptase gene mutation at codon 215 in HIV-infected infants
    Kamkamidze, G
    Sullivan, T
    Charbonneau, T
    JOURNAL OF CLINICAL VIROLOGY, 2001, 22 (01) : 143 - 148
  • [7] Impact of the N348I Mutation in HIV-1 Reverse Transcriptase on Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Non-Subtype B HIV-1
    McCormick, Adele L.
    Parry, Chris M.
    Crombe, Anne
    Goodall, Ruth L.
    Gupta, Ravindra K.
    Kaleebu, Pontiano
    Kityo, Cissy
    Chirara, Michael
    Towers, Greg J.
    Pillay, Deenan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (04) : 1806 - 1809
  • [8] Impaired rescue of chain-terminated DNA synthesis associated with the L74V mutation in HIV-1 reverse transcriptase
    Frankel, F
    Turner, D
    Brenner, B
    Quan, Y
    Wainberg, MA
    ANTIVIRAL THERAPY, 2004, 9 (04) : U39 - U39
  • [9] Mutation patterns of the reverse transcriptase genes in HIV-1 infected patients receiving combinations of nucleoside and non nucleoside inhibitors
    Re, MC
    Bon, I
    Monari, P
    Borderi, M
    Gibellini, D
    Schiavone, P
    Vitone, F
    Chiodo, F
    La Placa, M
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 22 (04) : 388 - 394
  • [10] Reverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription
    Warren, Kylie
    Warrilow, David
    Meredith, Luke
    Harrich, David
    VIRUSES-BASEL, 2009, 1 (03): : 873 - 894
12345